A
Ardelyx, Inc. Tech Stack
Commercial biopharmaceutical company with two FDA-approved GI medicines and Phase 3 pipeline
Ardelyx is a publicly traded biopharmaceutical company commercializing tenapanor-based therapies for gastrointestinal disorders, with two approved products (IBSRELA and XPHOZAH) already generating revenue. The hiring velocity is accelerating with 32 roles posted in the last 30 days, predominantly in sales (12) and healthcare operations (7), signaling aggressive market expansion — notably absent is meaningful engineering or data hiring, which aligns with a commercial-stage company focused on go-to-market execution and regulatory compliance rather than platform development.
Tech Stack 21 technologies
Core StackSAS Workday SAP Oracle Salesforce Azure AD AWS Smartsheet Tableau LIMS Veeva Paylocity Tilt Veeva RIM Microsoft Defender XDR Microsoft Sentinel Microsoft Purview Azure Azure Logic Apps Medidata X
What Ardelyx, Inc. Is Building
◆Challenges
- Regulatory submissions
- Patient access
- Sales goals
- Competitive markets
- Strengthening compliance
- Ensuring reliable supply
- On-time trial execution
- Regulatory compliance in life sciences
- Optimizing product access
- Modernizing enterprise technology stack
▲Active Projects
- First-in-class product launch in gastroenterology
- Quality and process improvement initiatives
- Product opportunity optimization for large gastroenterology group practices
- Analytical method development and validation
- Strategic roadmap for ad/qc department
- Edc/irt set-up and management
- Dashboard and tracker development
- B2b access marketing tactics
- Pull-through resources
- Market research needs and gaps
Hiring Activity
40 roles · 30 in 30d
Department
Seniority
Notable leadership hires: Business Director, Benefits Director
Company intelligence
